◆英語タイトル:Becton Dickinson and Co (BDX) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C13754
◆発行会社(調査会社):
GlobalData
◆発行日:2019年2月
◆ページ数:72
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:医療機器
◆販売価格オプション(消費税別)
※
販売価格オプションの説明はこちらで、
ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
※
GlobalData社の概要はこちらでご確認いただけます。
【レポートの概要】
Becton Dickinson and Co (BDX) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Becton Dickinson and Co (BD) is a medical technology company that manufactures and sells medical devices, reagents and instruments. Its major products include syringes and pen needles; intravenous catheters; infusion pumps and disposables; automated medication dispensing and supply management systems; prefillable drug delivery systems; respiratory ventilation and diagnostics equipment and consumables; products for the safe collection and transport of diagnostics specimens; instruments and reagent systems to detect a broad range of infectious diseases, healthcare-associated infections and cancers and various clinical research tools. BD offers its products to life science researchers, healthcare institutions, clinical laboratories, pharmaceutical industry and general public. The company sells its products in the Americas, Europe, the Middle East, Africa and Asia-Pacific. BD is headquartered in New Jersey, the US.
Becton Dickinson and Co Key Recent Developments
Feb 05,2019: BD announces results for 2019 first fiscal quarter; reaffirms fiscal 2019 guidance
Feb 05,2019: BD Announces Results for 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance
Feb 01,2019: IFP Gets Thumbs-Up to Launch BD
Jan 21,2019: Viva physicians to lead pan-industry collaboration to further evaluate the use of paclitaxel drug-eluting technologies in PAD
Jan 17,2019: BD announces preliminary results for 2019 first fiscal quarter; reaffirms fiscal 2019 guidance
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Becton Dickinson and Co – Key Facts
Becton Dickinson and Co – Key Employees
Becton Dickinson and Co – Key Employee Biographies
Becton Dickinson and Co – Major Products and Services
Becton Dickinson and Co – History
Becton Dickinson and Co – Company Statement
Becton Dickinson and Co – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Becton Dickinson and Co – Business Description
Business Segment: BD Interventional
Overview
Performance
Business Segment: BD Life Sciences
Overview
Performance
Business Segment: BD Medical
Overview
Performance
Geographical Segment: Europe
Target Markets
Performance
Geographical Segment: Greater Asia
Target Markets
Performance
Geographical Segment: Others
Target Markets
Performance
Geographical Segment: United States
Performance
R&D Overview
Becton Dickinson and Co – Corporate Strategy
Becton Dickinson and Co – SWOT Analysis
SWOT Analysis – Overview
Becton Dickinson and Co – Strengths
Becton Dickinson and Co – Weaknesses
Becton Dickinson and Co – Opportunities
Becton Dickinson and Co – Threats
Becton Dickinson and Co – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences, Power Financial Deals and Alliances
Becton Dickinson and Co, Medical Equipment, Deals By Year, 2013 to YTD 2019
Becton Dickinson and Co, Medical Equipment, Deals By Type, 2013 to YTD 2019
Becton Dickinson and Co, Recent Deals Summary
Section 5 – Company’s Recent Developments
Feb 05, 2019: BD announces results for 2019 first fiscal quarter; reaffirms fiscal 2019 guidance
Feb 05, 2019: BD Announces Results for 2019 First Fiscal Quarter; Reaffirms Fiscal 2019 Guidance
Jan 21, 2019: Viva physicians to lead pan-industry collaboration to further evaluate the use of paclitaxel drug-eluting technologies in PAD
Jan 17, 2019: BD announces preliminary results for 2019 first fiscal quarter; reaffirms fiscal 2019 guidance
Nov 06, 2018: BD announces results for 2018 fourth fiscal quarter and full year; provides fiscal 2019 guidance
Nov 06, 2018: BD announces results for 2018 fourth fiscal quarter and full year and also provides fiscal 2019 guidance
Oct 17, 2018: BD Donates 20 Million Syringes to Support Polio Eradication
Oct 16, 2018: BD launches molecular test for detecting tuberculosis and multi-drug resistant TB
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer
List of Tables
Becton Dickinson and Co, Key Facts
Becton Dickinson and Co, Key Employees
Becton Dickinson and Co, Key Employee Biographies
Becton Dickinson and Co, Major Products and Services
Becton Dickinson and Co, History
Becton Dickinson and Co, Other Locations
Becton Dickinson and Co, Subsidiaries
Becton Dickinson and Co, Key Competitors
Becton Dickinson and Co, Ratios based on current share price
Becton Dickinson and Co, Annual Ratios
Becton Dickinson and Co, Annual Ratios (Cont...1)
Becton Dickinson and Co, Annual Ratios (Cont...2)
Becton Dickinson and Co, Interim Ratios
Becton Dickinson and Co, Medical Equipment, Deals By Year, 2013 to YTD 2019
Becton Dickinson and Co, Medical Equipment, Deals By Type, 2013 to YTD 2019
Becton Dickinson and Co, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios
List of Figures
Becton Dickinson and Co, Performance Chart (2014 - 2018)
Becton Dickinson and Co, Ratio Charts
Becton Dickinson and Co, Medical Equipment, Deals By Year, 2013 to YTD 2019
Becton Dickinson and Co, Medical Equipment, Deals by Type, 2013 to YTD 2019